Citadel Advisors’s Corbus Pharmaceuticals CRBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-92,991
Closed -$494K 5988
2025
Q1
$494K Buy
+92,991
New +$494K ﹤0.01% 3993
2024
Q4
Hold
0
6097
2024
Q3
Sell
-332,761
Closed -$15.1M 5909
2024
Q2
$15.1M Sell
332,761
-36,406
-10% -$1.65M ﹤0.01% 1012
2024
Q1
$14.5M Buy
+369,167
New +$14.5M ﹤0.01% 1059
2023
Q1
Sell
-230
Closed -$762 5996
2022
Q4
$762 Buy
+230
New +$762 ﹤0.01% 5932
2022
Q3
Sell
-2,299
Closed -$17K 5987
2022
Q2
$17K Sell
2,299
-80
-3% -$592 ﹤0.01% 5742
2022
Q1
$38K Sell
2,379
-32,498
-93% -$519K ﹤0.01% 5991
2021
Q4
$644K Buy
34,877
+28,094
+414% +$519K ﹤0.01% 4314
2021
Q3
$208K Buy
6,783
+1,919
+39% +$58.8K ﹤0.01% 5388
2021
Q2
$267K Sell
4,864
-1,236
-20% -$67.8K ﹤0.01% 5325
2021
Q1
$361K Buy
6,100
+2,463
+68% +$146K ﹤0.01% 4861
2020
Q4
$136K Buy
+3,637
New +$136K ﹤0.01% 4607
2020
Q3
Sell
-42,095
Closed -$10.6M 4740
2020
Q2
$10.6M Sell
42,095
-3,971
-9% -$1,000K ﹤0.01% 1052
2020
Q1
$7.24M Buy
46,066
+45,401
+6,827% +$7.14M ﹤0.01% 1206
2019
Q4
$109K Buy
+665
New +$109K ﹤0.01% 4267
2019
Q3
Hold
0
4718
2019
Q2
Sell
-4,397
Closed -$917K 4694
2019
Q1
$917K Buy
4,397
+501
+13% +$104K ﹤0.01% 2901
2018
Q4
$683K Buy
3,896
+2,657
+214% +$466K ﹤0.01% 3065
2018
Q3
$281K Sell
1,239
-247
-17% -$56K ﹤0.01% 3531
2018
Q2
$226K Buy
1,486
+770
+108% +$117K ﹤0.01% 3609
2018
Q1
$131K Buy
716
+104
+17% +$19K ﹤0.01% 3588
2017
Q4
$130K Buy
+612
New +$130K ﹤0.01% 3474
2017
Q3
Sell
-810
Closed -$153K 3722
2017
Q2
$153K Buy
810
+213
+36% +$40.2K ﹤0.01% 3224
2017
Q1
$148K Buy
+597
New +$148K ﹤0.01% 3261
2016
Q3
Sell
-356
Closed -$32K 3621
2016
Q2
$32K Buy
+356
New +$32K ﹤0.01% 3121
2016
Q1
Sell
-342
Closed -$17K 3417
2015
Q4
$17K Buy
+342
New +$17K ﹤0.01% 3692